|
Dickman, Paul W; Holm, Lars-Erik; Lundell, Goran et al. (2003) Thyroid cancer risk after thyroid examination with 131I: a population-based cohort study in Sweden. Int J Cancer 106:580-7
|
|
Hall, P; Mattsson, A; Boice Jr, J D (1996) Thyroid cancer after diagnostic administration of iodine-131. Radiat Res 145:86-92
|
|
Hall, P; Lundell, G; Holm, L E (1993) Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol (Copenh) 128:230-4
|
|
Hall, P; Berg, G; Bjelkengren, G et al. (1992) Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer 50:886-90
|
|
Hall, P; Boice Jr, J D; Berg, G et al. (1992) Leukaemia incidence after iodine-131 exposure. Lancet 340:1-4
|
|
Hall, P; Holm, L E; Lundell, G et al. (1992) Tumors after radiotherapy for thyroid cancer. A case-control study within a cohort of thyroid cancer patients. Acta Oncol 31:403-7
|
|
Holm, L E; Hall, P; Wiklund, K et al. (1991) Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 83:1072-7
|
|
Hall, P; Holm, L E; Lundell, G et al. (1991) Cancer risks in thyroid cancer patients. Br J Cancer 64:159-63
|
|
Holm, L E (1991) Cancer risks after diagnostic doses of 131I with special reference to thyroid cancer. Cancer Detect Prev 15:27-30
|
|
Hall, P; Holm, L E; Lundell, G (1990) Second primary tumors following thyroid cancer. A Swedish record-linkage study. Acta Oncol 29:869-73
|
Showing the most recent 10 out of 11 publications
